151 related articles for article (PubMed ID: 38627588)
1. Circular ZDHHC11 supports Burkitt lymphoma growth independent of its miR-150 binding capacity.
Liu Y; Zhao X; Seitz A; Hooijsma AA; Ravanbakhsh R; Sheveleva S; de Jong D; Koerts J; Dzikiewicz-Krawczyk A; van den Berg A; Ziel-Swier LJYM; Kluiver J
Sci Rep; 2024 Apr; 14(1):8730. PubMed ID: 38627588
[TBL] [Abstract][Full Text] [Related]
2. The Role of the MYC/miR-150/MYB/ZDHHC11 Network in Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma.
Ziel-Swier LJYM; Liu Y; Seitz A; de Jong D; Koerts J; Rutgers B; Veenstra R; Razak FRA; Dzikiewicz-Krawczyk A; van den Berg A; Kluiver J
Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205272
[TBL] [Abstract][Full Text] [Related]
3. MiR-29 silencing modulates the expression of target genes related to proliferation, apoptosis and methylation in Burkitt lymphoma cells.
Mazzoccoli L; Robaina MC; Apa AG; Bonamino M; Pinto LW; Queiroga E; Bacchi CE; Klumb CE
J Cancer Res Clin Oncol; 2018 Mar; 144(3):483-497. PubMed ID: 29318382
[TBL] [Abstract][Full Text] [Related]
4. ZDHHC11 and ZDHHC11B are critical novel components of the oncogenic MYC-miR-150-MYB network in Burkitt lymphoma.
Dzikiewicz-Krawczyk A; Kok K; Slezak-Prochazka I; Robertus JL; Bruining J; Tayari MM; Rutgers B; de Jong D; Koerts J; Seitz A; Li J; Tillema B; Guikema JE; Nolte IM; Diepstra A; Visser L; Kluiver J; van den Berg A
Leukemia; 2017 Jun; 31(6):1470-1473. PubMed ID: 28331227
[No Abstract] [Full Text] [Related]
5. Integrative microRNA and mRNA deep-sequencing expression profiling in endemic Burkitt lymphoma.
Oduor CI; Kaymaz Y; Chelimo K; Otieno JA; Ong'echa JM; Moormann AM; Bailey JA
BMC Cancer; 2017 Nov; 17(1):761. PubMed ID: 29132323
[TBL] [Abstract][Full Text] [Related]
6. Low expression of miR-150 in pediatric intestinal Burkitt lymphoma.
Wang M; Yang W; Li M; Li Y
Exp Mol Pathol; 2014 Apr; 96(2):261-6. PubMed ID: 24613688
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitor prevents cell growth in Burkitt's lymphoma by regulating PI3K/Akt pathways and leads to upregulation of miR-143, miR-145, and miR-101.
Ferreira AC; Robaina MC; Rezende LM; Severino P; Klumb CE
Ann Hematol; 2014 Jun; 93(6):983-93. PubMed ID: 24577510
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA let-7a down-regulates MYC and reverts MYC-induced growth in Burkitt lymphoma cells.
Sampson VB; Rong NH; Han J; Yang Q; Aris V; Soteropoulos P; Petrelli NJ; Dunn SP; Krueger LJ
Cancer Res; 2007 Oct; 67(20):9762-70. PubMed ID: 17942906
[TBL] [Abstract][Full Text] [Related]
9. FAMLF is a target of miR-181b in Burkitt lymphoma.
Li JG; Ding Y; Huang YM; Chen WL; Pan LL; Li Y; Chen XL; Chen Y; Wang SY; Wu XN
Braz J Med Biol Res; 2017 May; 50(6):e5661. PubMed ID: 28492808
[TBL] [Abstract][Full Text] [Related]
10. Proliferation-promoting roles of linear and circular PVT1 are independent of their ability to bind miRNAs in B-cell lymphoma.
Zhao X; van den Berg A; Winkle M; Koerts J; Seitz A; de Jong D; Rutgers B; van der Sluis T; Bakker E; Kluiver J
Int J Biol Macromol; 2023 Dec; 253(Pt 2):126744. PubMed ID: 37689284
[TBL] [Abstract][Full Text] [Related]
11. Re-expression of microRNA-150 induces EBV-positive Burkitt lymphoma differentiation by modulating c-Myb in vitro.
Chen S; Wang Z; Dai X; Pan J; Ge J; Han X; Wu Z; Zhou X; Zhao T
Cancer Sci; 2013 Jul; 104(7):826-34. PubMed ID: 23521217
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor 3 (TCF3) combined with histone deacetylase 3 (HDAC3) down-regulates microRNA-101 to promote Burkitt lymphoma cell proliferation and inhibit apoptosis.
Dong L; Huang J; Zu P; Liu J; Gao X; Du J; Li Y
Bioengineered; 2021 Dec; 12(1):7995-8005. PubMed ID: 34658308
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas.
Schneider C; Setty M; Holmes AB; Maute RL; Leslie CS; Mussolin L; Rosolen A; Dalla-Favera R; Basso K
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8185-90. PubMed ID: 24843176
[TBL] [Abstract][Full Text] [Related]
14. miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.
Zajdel M; Rymkiewicz G; Chechlinska M; Blachnio K; Pienkowska-Grela B; Grygalewicz B; Goryca K; Cieslikowska M; Bystydzienski Z; Swoboda P; Walewski J; Siwicki JK
Tumour Biol; 2015 Jul; 36(7):5377-88. PubMed ID: 25677902
[TBL] [Abstract][Full Text] [Related]
15. miR-150 might inhibit cell proliferation and promote cell apoptosis by targeting LMO4 in Burkitt lymphoma.
Zhang D; Wei Y; Zhou J; Wang G; Xiao L; Xu J; Wei N; Li W; Zhang M
J Cell Physiol; 2019 Jun; 234(6):9652-9662. PubMed ID: 30422313
[TBL] [Abstract][Full Text] [Related]
16. miR-129 targets CDK1 and iASPP to modulate Burkitt lymphoma cell proliferation in a TAp63-dependent manner.
Zou H; Zou R; Chen K; Zhu C; Tian X; You Y; He X
J Cell Biochem; 2018 Nov; 119(11):9217-9228. PubMed ID: 30105797
[TBL] [Abstract][Full Text] [Related]
17. Lack of BIC and microRNA miR-155 expression in primary cases of Burkitt lymphoma.
Kluiver J; Haralambieva E; de Jong D; Blokzijl T; Jacobs S; Kroesen BJ; Poppema S; van den Berg A
Genes Chromosomes Cancer; 2006 Feb; 45(2):147-53. PubMed ID: 16235244
[TBL] [Abstract][Full Text] [Related]
18. The lncRNA KTN1-AS1 co-regulates a variety of Myc-target genes and enhances proliferation of Burkitt lymphoma cells.
Winkle M; Tayari MM; Kok K; Duns G; Grot N; Kazimierska M; Seitz A; de Jong D; Koerts J; Diepstra A; Dzikiewicz-Krawczyk A; Steidl C; Kluiver J; van den Berg A
Hum Mol Genet; 2022 Dec; 31(24):4193-4206. PubMed ID: 35866590
[TBL] [Abstract][Full Text] [Related]
19. p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53.
Lindström MS; Klangby U; Wiman KG
Oncogene; 2001 Apr; 20(17):2171-7. PubMed ID: 11360201
[TBL] [Abstract][Full Text] [Related]
20. Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis.
Robaina MC; Mazzoccoli L; Arruda VO; Reis FR; Apa AG; de Rezende LM; Klumb CE
Exp Mol Pathol; 2015 Apr; 98(2):200-7. PubMed ID: 25746661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
